Peripheral PD-1 and Tim-3 percentages are associated with primary sites and pathological types of peritoneal neoplasms [PDF]
BMC Cancer, 2023 Purpose Programmed death-1 (PD-1) and T cell immunoglobulin and mucin-domain-containing molecule 3(Tim-3) may be used as the biomarkers for the therapy in patients with peritoneal neoplasms.
Huihui Hu +3 more
doaj +5 more sources
Peritoneal dissemination complicating morcellation of uterine mesenchymal neoplasms. [PDF]
PLoS ONE, 2012 BackgroundPower morcellation has become a common technique for the minimally invasive resection of uterine leiomyomas. This technique is associated with dissemination of cellular material throughout the peritoneum.
Michael A Seidman +5 more
doaj +7 more sources
The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms [PDF]
Cancer, 2020 The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of ovarian neoplasms specifically related to the management of peritoneal surface malignancy. These guidelines are developed with input from leading experts, including surgical oncologists, medical oncologists, gynecologic oncologists, pathologists ...
Chicago Consensus Working Group
semanticscholar +6 more sources
Hidden in Plain Sight: Peritoneal Tuberculosis Mimicking Ovarian Neoplasm—A Case Report [PDF]
Tropical Medicine and Infectious DiseaseTuberculosis remains the deadliest infectious disease worldwide. Among extrapulmonary forms, peritoneal tuberculosis stands out as a rare and challenging diagnosis, often mistaken for intra-abdominal neoplasms or peritoneal carcinomatosis.
Dolfus Santiago Romero-Rojas +6 more
doaj +4 more sources
Neoplasms in the trocar site and peritoneal papillary serous cystadenocarcinoma
Taiwanese Journal of Obstetrics & Gynecology, 2014 Chiung-Ru Lai
doaj +5 more sources
Treatment of peritoneal disease arising from mucinous vs. non-mucinous appendiceal neoplasms with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [PDF]
Pleura and PeritoneumNon-mucinous appendiceal neoplasms (NMAN) are rare. The role of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in treating peritoneal dissemination from NMAN is poorly defined.
Qin Rennie Xinrui +6 more
doaj +4 more sources
CT imaging review of uncommon peritoneal-based neoplasms: beyond carcinomatosis
The British Journal of Radiology, 2021 Pathologic involvement of the peritoneum can result from a wide variety of conditions, including both neoplastic and non-neoplastic entities. Neoplastic involvement of the peritoneal ligaments, mesenteries, and spaces from malignant spread of epithelial cancers, termed peritoneal carcinomatosis, is frequently encountered at CT evaluation.
Perry J, Pickhardt +3 more
semanticscholar +6 more sources
Aggressive Management of Peritoneal Carcinomatosis from Mucinous Appendiceal Neoplasms [PDF]
Annals of Surgical Oncology, 2012 Peritoneal carcinomatosis (PC) in the setting of mucinous appendiceal neoplasms is characterized by the intraperitoneal accumulation of mucinous ascites and mucin-secreting epithelial cells that leads to progressive compression of intra-abdominal organs, morbidity, and eventual death.
Frances, Austin +11 more
semanticscholar +4 more sources
Cytologic identification of serous neoplasms in peritoneal fluids [PDF]
Cancer, 2001 Recognition of serous neoplasms in peritoneal fluids and their subclassification into serous borderline tumors (SBT) and serous carcinomas (SCA) may be difficult. The objective of this study was to determine whether morphologic criteria can distinguish reactive mesothelial cells (RM), SBT, and SCA (grades 1-3) in peritoneal fluids.A blinded review of ...
M M, Weir, D A, Bell
openaire +3 more sources
Enigma portal: Peritoneal effusion in a patient with a myeloproliferative neoplasm [PDF]
Cytopathology, 2022 Quiz regarding the cytological analysis of peritoneal effusion in a patient with a history of myeloproliferative neoplasm.
Frankel, Diane +5 more
openaire +4 more sources